Table 1 Association between clinical variables and BM
Characteristic | No-BM (N = 321) | BM (N = 74) | Total (N = 395) |
|---|---|---|---|
BMI, kg/m2 | |||
 Mean (SD) | 22.4 (3.13) | 21.7 (3.02) | 22.2 (3.11) |
Gender | |||
 Female | 137 (42.7%) | 36 (48.6%) | 173 (43.8%) |
 Male | 184 (57.3%) | 38 (51.4%) | 222 (56.2%) |
Age, y | |||
 Mean (SD) | 59.1 (10.8) | 59.5 (8.90) | 59.2 (10.4) |
Histology | |||
 Adenocarcinoma | 248 (77.3%) | 67 (90.5%) | 315 (79.7%) |
 Squamous | 67 (20.9%) | 5 (6.8%) | 72 (18.2%) |
 Other | 6 (1.9%) | 2 (2.7%) | 8 (2.0%) |
Ki67 | |||
 Median [Min, Max] | 0.200 [0.0100, 0.900] | 0.300 [0.0500, 0.800] | 0.200 [0.0100, 0.900] |
T | |||
 Tis/1 | 166 (51.7%) | 23 (31.1%) | 189 (47.8%) |
 T2 | 88 (27.4%) | 23 (31.1%) | 111 (28.1%) |
 T3 | 22 (6.9%) | 7 (9.5%) | 29 (7.3%) |
 T4 | 45 (14.0%) | 21 (28.4%) | 66 (16.7%) |
N | |||
 N0 | 202 (62.9%) | 19 (25.7%) | 221 (55.9%) |
 N1 | 22 (6.9%) | 4 (5.4%) | 26 (6.6%) |
 N2 | 51 (15.9%) | 22 (29.7%) | 73 (18.5%) |
 N3 | 46 (14.3%) | 29 (39.2%) | 75 (19.0%) |
Stage | |||
 I | 167 (52.0%) | 0 (0%) | 167 (42.3%) |
 II | 27 (8.4%) | 0 (0%) | 27 (6.8%) |
 III | 58 (18.1%) | 0 (0%) | 58 (14.7%) |
 IV | 69 (21.5%) | 74 (100%) | 143 (36.2%) |
Chemotherapy | |||
 No | 185 (57.6%) | 40 (54.1%) | 225 (57.0%) |
 Yes | 136 (42.4%) | 34 (45.9%) | 170 (43.0%) |
CEA | |||
 < 5 ng/ml | 227 (70.7%) | 19 (25.7%) | 246 (62.3%) |
 ≥ 5 ng/ml | 94 (29.3%) | 55 (74.3%) | 149 (37.7%) |
NLR | |||
 Low | 128 (39.9%) | 54 (73.0%) | 182 (46.1%) |
 High | 193 (60.1%) | 20 (27.0%) | 213 (53.9%) |
PLR | |||
 Low | 115 (35.8%) | 42 (56.8%) | 157 (39.7%) |
 High | 206 (64.2%) | 32 (43.2%) | 238 (60.3%) |
AAPR | |||
 Low | 78 (24.3%) | 31 (41.9%) | 109 (27.6%) |
 High | 243 (75.7%) | 43 (58.1%) | 286 (72.4%) |
LMR | |||
 Low | 148 (46.1%) | 11 (14.9%) | 159 (40.3%) |
 High | 173 (53.9%) | 63 (85.1%) | 236 (59.7%) |